cold ischemia procedure
ProcedureCold ischemia followed by partial nephrectomy
NCT Number: NCT00743236
RATIONALE: Warm ischemia is the clamping of blood vessels without cooling the kidney. Cold ischemia is the clamping of blood vessels with kidney cooling. It is not yet known whether warm ischemia is more effective than cold ischemia in patients undergoing surgery for stage I kidney cancer.
PURPOSE: This randomized phase III trial is studying warm ischemia to see how well it works compared with cold ischemia during surgery in treating patients with stage I kidney cancer.
Looking for future studies?
Notify Me18 year–120 year
All sexes
Interventional
Not applicable
Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center, Orange, California, United States
OBJECTIVES:
Primary
Secondary
OUTLINE: This is a multicenter study. Patients are randomized to 1 of 2 treatment arms.
Patients are followed at 1, 3, 6, 9 , and 12 months after nephrectomy.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
DISEASE CHARACTERISTICS:
PATIENT CHARACTERISTICS:
PRIOR CONCURRENT THERAPY:
Cold ischemia followed by partial nephrectomy
Warm ischemia followed by partial nephrectomy
Time frame: at 1 year after nephrectomy.
Time frame: at 1 year after nephrectomy.
Time frame: at 1 year after nephrectomy.
Time frame: at 1 year after nephrectomy.
Time frame: at 1 year after nephrectomy.
Wake Forest University Health Sciences
Other
A Phase III Multi-Institutional Randomized Clinical Trial: Effect of Type of Ischemia - Warm vs Cold During Partial Nephrectomy - on Renal Function
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00403169
Adenocarcinoma, Carcinoma
Cleveland, Ohio, United States
View Trial DetailsNCT03455452
Adenocarcinoma, Adenocarcinoma Of Kidney
Paris, France
View Trial DetailsNCT00814021
Adenocarcinoma, Brain Diseases
Toulouse, France
View Trial DetailsNCT01120249
Adenocarcinoma, Carcinoma
Birmingham, Alabama, United States
View Trial Details